Name: | COLGATE ORAL PHARMACEUTICALS, INC. |
Jurisdiction: | New York |
Legal type: | FOREIGN BUSINESS CORPORATION |
Status: | Active |
Date of registration: | 14 Apr 1993 (32 years ago) |
Entity Number: | 1718472 |
County: | New York |
Place of Formation: | Delaware |
Principal Address: | 300 PARK AVENUE, NEW YORK, NY, United States, 10022 |
Principal Address ZIP Code: | 10022 |
Address: | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
Address ZIP Code: | 10005 |
CAGE number | Status | Type | Established | CAGE Update Date | CAGE Expiration | SAM Expiration | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
63417 | Active | U.S./Canada Manufacturer | 1983-09-10 | 2024-05-22 | 2029-05-22 | 2025-04-26 | |||||||||||||||
|
POC | JEFF SEDOR |
Phone | +1 914-356-6671 |
Fax | +1 212-310-2317 |
Address | 300 PARK AVE, NEW YORK, NY, 10022 7402, UNITED STATES |
Ownership of Offeror Information
Highest Level Owner | Information not Available |
---|
Immediate Level Owner | Information not Available |
---|
List of Offerors (0) | Information not Available |
---|
Name | Role | Address |
---|---|---|
COLGATE ORAL PHARMACEUTICALS, INC. | DOS Process Agent | 28 LIBERTY STREET, NEW YORK, NY, United States, 10005 |
Name | Role | Address |
---|---|---|
C T CORPORATION SYSTEM | Agent | 28 LIBERTY ST., NEW YORK, NY, 10005 |
Name | Role | Address |
---|---|---|
BARRY REICHGOTT | Chief Executive Officer | 300 PARK AVENUE, NEW YORK, NY, United States, 10022 |
Start date | End date | Type | Value |
---|---|---|---|
2023-04-14 | 2023-04-14 | Address | 300 PARK AVENUE, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer) |
2021-05-26 | 2023-04-14 | Address | 300 PARK AVENUE, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer) |
2019-04-10 | 2023-04-14 | Address | 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
2019-01-28 | 2023-04-14 | Address | 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Registered Agent) |
2019-01-28 | 2019-04-10 | Address | 28 LIBERTY ST., NEW YORK, NY, 10005, USA (Type of address: Service of Process) |
2017-04-04 | 2021-05-26 | Address | 300 PARK AVENUE, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer) |
2015-04-02 | 2017-04-04 | Address | 300 PARK AVENUE, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer) |
2013-04-08 | 2015-04-02 | Address | 300 PARK AVE, NEW YORK, NY, 10022, USA (Type of address: Principal Executive Office) |
2013-04-08 | 2015-04-02 | Address | 300 PARK AVENUE, NEW YORK, NY, 10022, USA (Type of address: Chief Executive Officer) |
2005-08-03 | 2013-04-08 | Address | 1 COLGATE WAY, CANTON, MA, 02021, USA (Type of address: Chief Executive Officer) |
Filing Number | Date Filed | Type | Effective Date |
---|---|---|---|
230414003808 | 2023-04-14 | BIENNIAL STATEMENT | 2023-04-01 |
210526060147 | 2021-05-26 | BIENNIAL STATEMENT | 2021-04-01 |
190410060598 | 2019-04-10 | BIENNIAL STATEMENT | 2019-04-01 |
SR-20557 | 2019-01-28 | CERTIFICATE OF CHANGE (BY AGENT) | 2019-01-28 |
SR-20556 | 2019-01-28 | CERTIFICATE OF CHANGE (BY AGENT) | 2019-01-28 |
170404006879 | 2017-04-04 | BIENNIAL STATEMENT | 2017-04-01 |
150402007285 | 2015-04-02 | BIENNIAL STATEMENT | 2015-04-01 |
130408002343 | 2013-04-08 | BIENNIAL STATEMENT | 2013-04-01 |
050803002434 | 2005-08-03 | BIENNIAL STATEMENT | 2005-04-01 |
030407002966 | 2003-04-07 | BIENNIAL STATEMENT | 2003-04-01 |
Contract Type | Award or IDV Flag | PIID | Start Date | Current End Date | Potential End Date | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No data | IDV | 36F79723D0199 | 2023-09-01 | No data | No data | |||||||||||||||||||||||
|
Obligated Amount | 0.00 |
Potential Award Amount | 20974896.00 |
Description
Title | 65IB / ADMINISTRATIVE CHANGE: IFF SALES POC / SIGNATORY AUTHORITY (SA) FORM |
NAICS Code | 325412: PHARMACEUTICAL PREPARATION MANUFACTURING |
Product and Service Codes | 6505: DRUGS AND BIOLOGICALS |
Recipient Details
Recipient | COLGATE ORAL PHARMACEUTICALS, INC. |
UEI | JLQXXU773RB5 |
Recipient Address | UNITED STATES, 300 PARK AVE, NEW YORK, NEW YORK, NEW YORK, 100227402 |
Date of last update: 13 Nov 2024
Sources: New York Secretary of State